Literature DB >> 23846917

Tumor markers in pancreatic cancer: 2013.

Urvi Ajay Shah1, Muhammad Wasif Saif.   

Abstract

Amongst the tumor markers for pancreatic cancer CA 19-9 is being used most widely and newer clinically useful applications of this tumor marker are being researched. We will discuss four abstracts presented at the American Society of Clinical Oncology (ASCO) Annual Meeting which contribute to expanding the application of CA 19-9 measurement (Abstracts #4042, #4058, #e15082, #e15146).

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23846917     DOI: 10.6092/1590-8577/1653

Source DB:  PubMed          Journal:  JOP        ISSN: 1590-8577


  6 in total

Review 1.  Prognostic factors related with survival in patients with pancreatic adenocarcinoma.

Authors:  Ahmet Bilici
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

2.  Recent advances in pancreatic cancer: updates and insights from the 2015 annual meeting of the American Society of Clinical Oncology.

Authors:  Matthew J Abrams; Kevin Rakszawski; Monali Vasekar; Frank Passero; Atif Abbas; Yuxia Jia; Muhammad Wasif Saif
Journal:  Therap Adv Gastroenterol       Date:  2016-03       Impact factor: 4.409

3.  Screening of Pancreatic Cancer.

Authors:  Muhammad Wasif Saif
Journal:  JOP       Date:  2018-05

Review 4.  Glycomic Approaches for the Discovery of Targets in Gastrointestinal Cancer.

Authors:  Stefan Mereiter; Meritxell Balmaña; Joana Gomes; Ana Magalhães; Celso A Reis
Journal:  Front Oncol       Date:  2016-03-09       Impact factor: 6.244

Review 5.  The glycosylation landscape of pancreatic cancer.

Authors:  Jennifer Munkley
Journal:  Oncol Lett       Date:  2019-01-03       Impact factor: 2.967

6.  MicroRNA-466 with tumor markers for cervical cancer screening.

Authors:  Li-Li Zhou; Yong Shen; Jiao-Mei Gong; Ping Sun; Jia-He Sheng
Journal:  Oncotarget       Date:  2017-08-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.